Cargando…
Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study
BACKGROUND: Growing evidence shows that viral co-infection is found repeatedly in patients with Coronavirus Disease–2019 (COVID-19). This is the first report of SARS-CoV-2 co-infection with viral respiratory pathogens in Indonesia. METHODS: Over a one month period of April to May 2020, SARS-CoV-2 po...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055379/ https://www.ncbi.nlm.nih.gov/pubmed/35531428 http://dx.doi.org/10.1016/j.amsu.2022.103676 |
_version_ | 1784697397093335040 |
---|---|
author | Arguni, Eggi Supriyati, Endah Hakim, Mohamad Saifudin Daniwijaya, Edwin Widyanto Makrufardi, Firdian Rahayu, Ayu Rovik, Anwar Saraswati, Utari Oktoviani, Farida Nur Prastiwi, Nenes Nuryastuti, Titik Wibawa, Tri Haryana, Sofia Mubarika |
author_facet | Arguni, Eggi Supriyati, Endah Hakim, Mohamad Saifudin Daniwijaya, Edwin Widyanto Makrufardi, Firdian Rahayu, Ayu Rovik, Anwar Saraswati, Utari Oktoviani, Farida Nur Prastiwi, Nenes Nuryastuti, Titik Wibawa, Tri Haryana, Sofia Mubarika |
author_sort | Arguni, Eggi |
collection | PubMed |
description | BACKGROUND: Growing evidence shows that viral co-infection is found repeatedly in patients with Coronavirus Disease–2019 (COVID-19). This is the first report of SARS-CoV-2 co-infection with viral respiratory pathogens in Indonesia. METHODS: Over a one month period of April to May 2020, SARS-CoV-2 positive nasopharyngeal swabs in our COVID-19 referral laboratory in Yogyakarta, Indonesia, were tested for viral respiratory pathogens by real-time, reverse transcription polymerase chain reaction (RT-PCR). Proportion of co-infection reported in percentage. RESULTS: Fifty-nine samples were positive for other viral respiratory pathogens among a total of 125 samples. Influenza A virus was detected in 32 samples, Influenza B in 16 samples, Human metapneumovirus in 1 sample, and adenovirus in 10 samples. We did not detect any co-infection with respiratory syncytial virus. Nine (7.2%) patients had co-infection with more than two viruses. CONCLUSION: Viral co-infection with SARS-CoV-2 is common. These results will provide a helpful reference for diagnosis and clinical treatment of patients with COVID-19. |
format | Online Article Text |
id | pubmed-9055379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-90553792022-05-02 Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study Arguni, Eggi Supriyati, Endah Hakim, Mohamad Saifudin Daniwijaya, Edwin Widyanto Makrufardi, Firdian Rahayu, Ayu Rovik, Anwar Saraswati, Utari Oktoviani, Farida Nur Prastiwi, Nenes Nuryastuti, Titik Wibawa, Tri Haryana, Sofia Mubarika Ann Med Surg (Lond) Cross-sectional Study BACKGROUND: Growing evidence shows that viral co-infection is found repeatedly in patients with Coronavirus Disease–2019 (COVID-19). This is the first report of SARS-CoV-2 co-infection with viral respiratory pathogens in Indonesia. METHODS: Over a one month period of April to May 2020, SARS-CoV-2 positive nasopharyngeal swabs in our COVID-19 referral laboratory in Yogyakarta, Indonesia, were tested for viral respiratory pathogens by real-time, reverse transcription polymerase chain reaction (RT-PCR). Proportion of co-infection reported in percentage. RESULTS: Fifty-nine samples were positive for other viral respiratory pathogens among a total of 125 samples. Influenza A virus was detected in 32 samples, Influenza B in 16 samples, Human metapneumovirus in 1 sample, and adenovirus in 10 samples. We did not detect any co-infection with respiratory syncytial virus. Nine (7.2%) patients had co-infection with more than two viruses. CONCLUSION: Viral co-infection with SARS-CoV-2 is common. These results will provide a helpful reference for diagnosis and clinical treatment of patients with COVID-19. Elsevier 2022-04-30 /pmc/articles/PMC9055379/ /pubmed/35531428 http://dx.doi.org/10.1016/j.amsu.2022.103676 Text en © 2022 Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Cross-sectional Study Arguni, Eggi Supriyati, Endah Hakim, Mohamad Saifudin Daniwijaya, Edwin Widyanto Makrufardi, Firdian Rahayu, Ayu Rovik, Anwar Saraswati, Utari Oktoviani, Farida Nur Prastiwi, Nenes Nuryastuti, Titik Wibawa, Tri Haryana, Sofia Mubarika Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study |
title | Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study |
title_full | Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study |
title_fullStr | Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study |
title_full_unstemmed | Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study |
title_short | Co-infection of SARS-CoV-2 with other viral respiratory pathogens in Yogyakarta, Indonesia: A cross-sectional study |
title_sort | co-infection of sars-cov-2 with other viral respiratory pathogens in yogyakarta, indonesia: a cross-sectional study |
topic | Cross-sectional Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055379/ https://www.ncbi.nlm.nih.gov/pubmed/35531428 http://dx.doi.org/10.1016/j.amsu.2022.103676 |
work_keys_str_mv | AT argunieggi coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy AT supriyatiendah coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy AT hakimmohamadsaifudin coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy AT daniwijayaedwinwidyanto coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy AT makrufardifirdian coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy AT rahayuayu coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy AT rovikanwar coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy AT saraswatiutari coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy AT oktovianifaridanur coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy AT prastiwinenes coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy AT nuryastutititik coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy AT wibawatri coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy AT haryanasofiamubarika coinfectionofsarscov2withotherviralrespiratorypathogensinyogyakartaindonesiaacrosssectionalstudy |